FOXO3A Haplotype Profiling for Longevity and Aging Risk
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing studies have struggled to identify genetic factors that significantly influence human longevity and healthy aging, with limited replication across populations and challenges in studying complex phenotypes like human lifespan.
Innovation Solution
The use of FOXO3A polymorphisms and haplotypes, particularly the 'GCC' haplotype, to predict longevity and healthy aging by analyzing genetic variations in a large, homogeneous Japanese population, leveraging insights from model organisms and human studies to identify genetic markers associated with increased lifespan and reduced risk of age-related diseases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If genetic factors are studied to identify influences on human longevity, then understanding of aging mechanisms is improved, but replication across populations is limited and study complexity increases
Solution Approach 1:
The study segments the complex genetic analysis by focusing on a specific population (Japanese) with homogeneous characteristics, breaking down the broader problem of universal genetic aging factors into a manageable subset that can be studied with greater depth and precision
Solution Approach 2:
The invention applies local quality by tailoring the genetic study approach to the specific characteristics of the Japanese population, using population-specific genetic markers and haplotypes that are particularly relevant to this group rather than applying a universal approach
2Measurement precision
If complex phenotypes like human lifespan are studied, then comprehensive understanding of aging is improved, but study difficulty and resource requirements increase
Solution Approach 1:
The study extracts and isolates specific genetic components (FOXO3A polymorphisms and haplotypes) from the complex web of genetic factors influencing aging, allowing focused analysis on elements most likely to contribute to longevity while simplifying the overall study design
Solution Approach 2:
The invention changes the parameters of the study by defining specific operational criteria for longevity (e.g., surviving to age 100 or beyond) and focusing on particular genetic variants, transforming the abstract concept of 'human lifespan' into measurable, discrete parameters that can be analyzed systematically
Data Source
AI summary
The invention provides methods and compositions relating to identification and use of genetic information from the FOXO3A gene that can be used for determining and increasing an individual's likelihood of longevity and of retaining physical and cognitive function during aging, and for determining and decreasing an individual's likelihood of developing a cardiovascular-, metabolic- or age-related disease, including coronary artery (heart) disease, stroke, cancer, chronic pulmonary disease, diabetes, Parkinson's disease and dementia.